Literature DB >> 11518624

The ovarian hormones and absence epilepsy: a long-term EEG study and pharmacological effects in a genetic absence epilepsy model.

G van Luijtelaar1, B Budziszewska, L Jaworska-Feil, J Ellis, A Coenen, W Lasoń.   

Abstract

In the first experiment, the relationship between the phase of the estrous cycle and the number of spontaneously occurring spike-wave discharges was investigated in WAG/Rij rats, a model for generalized absence epilepsy. The electroencephalogram (EEG) was continuously recorded for 96 h in eight rats chronically equipped with cortical EEG electrodes. A circadian pattern emerged for the number of spike-wave discharges: a nadir during the first hours of the light period, and an acrophase during the first hours of the dark period. This daily maximum was increased at proestrus day compared with the other days of the cycle, when the plasma level of progesterone is enhanced specifically at these hours of this day. This suggests that progesterone enhances spike-wave discharges. There was no difference in the first few hours of the light period in the number of spike-wave discharges between proestrus and the three other days, suggesting that estradiol has no effect on spike-wave discharges. In the second study, the effects of the systemic administration of progesterone and 17 beta-estradiol on spike-wave discharges and spontaneous behavior were investigated. It was shown that progesterone (20 and 30 mg/kg) but not estradiol (0.17-1.5 mg/kg) increased the number and total duration of spike-wave discharges. On the other hand, injection of RU 38486 (10 and 30 mg/kg), an antagonist of intracellular progesterone receptors, had no effect on spike-wave discharges and did not block the stimulatory effect of progesterone. The antagonist of 17 beta-estradiol tamoxifen (1 and 3 mg/kg) did not evoke alterations in the number or duration of spike-wave discharges. Our results indicate that progesterone aggravates spike-wave discharges, but is not mediated through intracellular receptors. Since progesterone is rapidly metabolized in the brain to the positive modulator of GABA(A) receptor allopregnanolone, which increases spike-wave discharges in WAG/Rij rats, it is possible that the epileptiformic effects of progesterone are mediated through this metabolite.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11518624     DOI: 10.1016/s0920-1211(01)00277-7

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  12 in total

1.  The antiepileptic effect of sodium valproate during different phases of the estrous cycle in PTZ-induced seizures in rats.

Authors:  Jahangir Kaboutari; Morteza Zendehdel; Saeed Habibian; Mahmood Azimi; Mohammad Shaker; Behnaz Karimi
Journal:  J Physiol Biochem       Date:  2011-11-11       Impact factor: 4.158

2.  Extrasynaptic γ-aminobutyric acid type A receptor-mediated sex differences in the antiseizure activity of neurosteroids in status epilepticus and complex partial seizures.

Authors:  Doodipala Samba Reddy; Chase Matthew Carver; Bryan Clossen; Xin Wu
Journal:  Epilepsia       Date:  2019-03-20       Impact factor: 5.864

3.  Impact of strain, sex, and estrous cycle on gamma butyrolactone-evoked absence seizures in rats.

Authors:  Victor R Santos; Ihori Kobayashi; Robert Hammack; Gregory Danko; Patrick A Forcelli
Journal:  Epilepsy Res       Date:  2018-09-18       Impact factor: 3.045

Review 4.  Animal models of absence epilepsies: what do they model and do sex and sex hormones matter?

Authors:  Gilles van Luijtelaar; Filiz Yilmaz Onat; Martin J Gallagher
Journal:  Neurobiol Dis       Date:  2014-08-15       Impact factor: 5.996

5.  Neurochemical and behavioral features in genetic absence epilepsy and in acutely induced absence seizures.

Authors:  A S Bazyan; G van Luijtelaar
Journal:  ISRN Neurol       Date:  2013-05-07

Review 6.  Sex Differences in the Epilepsies and Associated Comorbidities: Implications for Use and Development of Pharmacotherapies.

Authors:  Catherine A Christian; Doodipala Samba Reddy; Jamie Maguire; Patrick A Forcelli
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

Review 7.  Neurosteroid replacement therapy for catamenial epilepsy.

Authors:  Doodipala S Reddy; Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

Review 8.  Establishing Drug Effects on Electrocorticographic Activity in a Genetic Absence Epilepsy Model: Advances and Pitfalls.

Authors:  Gilles van Luijtelaar; Gerard van Oijen
Journal:  Front Pharmacol       Date:  2020-04-14       Impact factor: 5.810

9.  Absence epilepsy in male and female WAG/Rij rats: A longitudinal EEG analysis of seizure expression.

Authors:  Willian Lazarini-Lopes; Carolina Campos-Rodriguez; Devin Palmer; Prosper N'Gouemo; Norberto Garcia-Cairasco; Patrick A Forcelli
Journal:  Epilepsy Res       Date:  2021-06-22       Impact factor: 2.991

Review 10.  Circadian Rhythms and Epilepsy: A Suitable Case for Absence Epilepsy.

Authors:  Magdalena K Smyk; Gilles van Luijtelaar
Journal:  Front Neurol       Date:  2020-04-28       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.